India’s API market, valued at US$14.2 billion in 2025, is racing ahead at 8.5% CAGR, and 3 pharma stocks are quietly powering this global surge.

Green Brick Partners offers superior growth, profitability, and value. Insider ownership in GRBK is high. See more investment analysis here.

Verizon's 7% dividend yield may raise some eyebrows, but the company made a big statement with its third-quarter earnings ...

Model Y Juniper refresh confirmed for May 2025 launch with new features including 8-inch rear touchscreen, ventilated seats, ...

From there, it becomes a question of which companies are resilient and innovating well and avoiding those that are becoming ...

Turning to guidance, Teradata warned that sales are still falling, with revenue probably down 2% to 4% year over year, and ...

Myriad Genetics (MYGN) stock is downgraded from a "Buy" to "Hold" due to flat Q3 2025 earnings and limited near-term revenue ...

Even though Berkshire Hathaway has lagged behind the broader market over the past year, Wall Street analysts remain ...

Dutch Bros (BROS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth ...

Oklo Inc (NYSE: OKLO) shares are rebounding Wednesday morning, trading higher after a volatile, two-day slide.

Target, Coca-Cola, Sirius XM, Verizon, and Starbucks offer patient investors quarterly dividend checks as they wait out turnaround strategies. Target and Coca-Cola have boosted their payouts annually ...

Gildan Activewear stock is a top TSX stock you can own in 2025, given its steady revenue and earnings growth estimate.